Cedars-Sinai performs more than 250 kidney transplants per year. According to Irene Kim, MD, 30 percent of these patients have a highly sensitized immune system, causing them to reject the transplant due to the antibodies their bodies produce. Determined to make kidney transplants an option for everyone, researchers at Cedars-Sinai have discovered a new pathway to treat patients with antibody rejection.
For Healthcare Professionals: To claim CME credit for this activity, please click here link to be redirected to the Cedars-Sinai CME Portal.
Created by
Related Presenters
Surgeon-In-Chief
Vice Dean, Avademic Affairs
The research of Bruce L. Gewertz, MD, focuses on human factors in delivery of health care and the distribution of surgical service. His clinical interests include cerebrovascular disease, especially intraoperative neurophysiologic monitoring ...
Transplant Surgery
CEDARS-SINAI APPOINTMENTS Professor Cedars-Sinai, Surgery Director, Division of Transplant Cedars-Sinai, Surgery Co-Director, Comprehensive Transplant Center Cedars-Sinai, Surgery Surgical Director, ...
BROADCASTMED